Relenza is a darn good drug. Don't discount it.
Inavir still smashed it.
End result. This great result for LANI makes me feel ill in light of the BARDA decision. We have a blockbuster drug. Will it ever get to market in the USA. Highly Unlikely as it stands today.
I'm lost for words.
Still holding and hoping for a hostile take over.
